REGN - Spark Newswire

2 minute read

Regeneron Pharmaceuticals Whale Trades Spotted

Today, 8:44 AM

A whale with a lot of money to spend has taken a noticeably bearish stance on Regeneron Pharmaceuticals. Looking at options history for Regeneron Pharmaceuticals (NASDAQ:REGN) we detected 11 strange trades.

REGN

2 minute read

M&A
News

Completion of the Acquisition of Checkmate Pharmaceuticals by Regeneron Pharmaceuticals Triggers $2.5M Milestone Payment to XOMA

By Charles Gross

Today, 8:44 AM

Kuros Biosciences AG ("Kuros" or the "Company"), a leader in next generation bone graft technologies, notes the completion of the acquisition of Checkmate Pharmaceuticals (NASDAQ: CMPI) by Regeneron Pharmaceuticals (NASDAQ: REGN).

CMPI

5 minute read

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

By Shanthi Rexaline

Today, 8:44 AM

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and Drug Administration approved by May 2021.

ACAD

2 minute read

Analyst Ratings

7 Analysts Have This to Say About Regeneron Pharmaceuticals

By Benzinga Insights

Today, 8:44 AM

Over the past 3 months, 7 analysts have published their opinion on Regeneron Pharmaceuticals (NASDAQ:REGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

REGN

1 minute read

FDA Accepts Regeneron, Sanofi’s Filing For Review In Skin Disease

By Ragothaman Srinivasan

Today, 8:44 AM

The U.S.

REGN

1 minute read

Argus Research Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $760

By Benzinga Newsdesk

Today, 8:44 AM

Argus Research analyst Jasper Hellweg maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $680 to $760.

REGN

4 minute read

As COVID Subsidies, Here Are 8 Infectious Diseases That Could Emerge As Potent Threats

By Shanthi Rexaline

Today, 8:44 AM

The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data provided by New York Times.

IBB

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For May 23, 2022

By Benzinga Insights

Today, 8:44 AM

ABBV

2 minute read

Regeneron’s Evkeeza Reduces Bad Cholesterol By 48% In Children Aged 5-11 Years

By Vandana Singh

Today, 8:44 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced positive results from a Phase 3 trial evaluating Evkeeza (evinacumab) in children aged 5 to 11…

RARE

2 minute read

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

By Shanthi Rexaline

Today, 8:44 AM

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

ABBV

Feed Symbols: REGN